课题基金 / 基金详情

Gene Therapy for Long-Term Myocardial Protection

Gene Therapy for Long-Term Myocardial Protection
长期心肌保护的基因治疗
批准号:
8449674
负责人:
Victor J Dzau
金额:
$34.74万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-05-02 至 2014-03-31
关键词:
AcuteAcute myocardial infarctionAddressAnimalsAnti-Inflammatory AgentsAnti-inflammatoryAntigensAntioxidantsAnusApoptosisApoptoticAreaArrhythmiaAutopsyBerylliumBilirubinBiochemicalBiodistributionBiological AssayBiological MarkersBiological PreservationBloodBrain Hypoxia-IschemiaCarbon MonoxideCardiacCatabolismCathetersCell DeathCell RespirationCell SurvivalClinicalCongestive Heart FailureCoronaryCoronary arteryCytomegalovirusDevelopmentDimensionsDoseDrug Delivery SystemsEchocardiographyEffectivenessElectrolytesElementsEnzymesFamily suidaeFibrosisFlow CytometryFluorescenceFutureGene DeliveryGene TransferGenerationsGenesGoalsHeartHeart DiseasesHemeHemorrhageHistologicHomeostasisHourHumanHypoxiaHypoxia-Responsive ElementsImageInfarctionInflammationInfusion proceduresInjection of therapeutic agentInjuryIntravenousIschemiaKidneyLeft Ventricular FunctionLeft ventricular structureLiverMagnetic Resonance ImagingMaintenanceMature T-LymphocyteMeasurementMeasuresMediatingMembrane PotentialsMetabolicMetabolismMethodsMicrocirculationMicroscopyMitochondriaModelingMolecularMolecular AnalysisMonitorMuscle CellsMyocardialMyocardial InfarctionMyocardial IschemiaMyocardial ReperfusionMyocardiumOrganOrphanOutcomeOxidative StressPathway interactionsPatientsPerformancePerfusionPeripheralPharmaceutical PreparationsPhasePhysiologicalProcessPropertyRandomizedRattusReaction TimeRecovery of FunctionRegulationReperfusion InjuryReperfusion TherapyResistanceRetinoidsReverse Transcriptase Polymerase Chain ReactionRiskRodent ModelRoleRuptureSafetySerotypingSerumSiteStaphylococcal Enterotoxin BStructureStructure of left gastric veinSuperoxide DismutaseSurfaceT cell transcription factor 1T-Cell DevelopmentT-LymphocyteTestisTherapeuticThymus GlandTimeTissue HarvestingTissue SampleTissuesTransgenesTransgenic OrganismsTranslationsTransmission Electron MicroscopyTreatment EfficacyTropismTroponinUniversitiesUp-RegulationValidationVentricularVentricular FunctionViralViral GenomeViral Load resultVirusWeightWestern BlottingWorkadaptive immunityadeno-associated viral vectorallograft rejectionbaseclinical applicationdesigndosageexperienceextracellulargene therapyheme oxygenase-1high riskmitochondrial membranemortalitynoveloutcome forecastpressurepublic health relevancereceptorresearch studyresponsetherapeutic genethymocytetransduction efficiencytransgene expressionvector

项目摘要

项目成果

Victor J Dzau的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):调节的细胞凋亡是胸腺T细胞发育的关键,并控制外周T细胞依赖的获得性免疫。T细胞因子1(TCF-1)的共激活因子2-连环蛋白(2-catenin)和维甲酸相关的孤儿受体γt(ROR3t)均通过上调抗凋亡的Bclxl来调节胸腺细胞的存活。在研究ROR3t的过程中,我们发现2-catenin/TCF-1是控制ROR3t介导的胸腺细胞存活的一个潜在的上游途径。TCF-1的缺失导致胸腺细胞的凋亡和ROR3t的下调,而稳定的2-连环蛋白(2-catenin,2-catenin)的转基因表达可以促进胸腺细胞的存活,上调ROR3t的表达。与其在胸腺细胞中的存活作用相反,2-catTg通过促进活化诱导的细胞死亡(AICD)上调促凋亡的BID和表面Fas,并增强超抗原葡萄球菌肠毒素B(SEB)诱导的外周T细胞的缺失。因此,我们假设2-连环蛋白/TCF通路在调节发育中的T细胞和外周成熟T细胞中的凋亡方面使用了不同的机制。在这项研究的前两个目标中,我们建议阐明2-连环蛋白/TCF-1调节胸腺细胞和外周T细胞凋亡的机制。在最后一个目标中,我们将确定是否可以通过操纵2-连环蛋白调节的T细胞存活来控制T细胞依赖的同种异体移植排斥反应。
英文摘要
DESCRIPTION (provided by applicant): Regulated apoptosis is critical to T cell development in the thymus and controls T cell- dependent adaptive immunity in periphery. 2-catenin, a coactivator of T cell factor 1 (TCF-1), and retinoid-related orphan receptor gamma t (ROR3t) both regulate thymocyte survival via the up-regulation of anti-apoptotic Bcl-xL. In the process of studying ROR3t, we have identified 2- catenin/TCF-1 as a potential upstream pathway that controls ROR3t-mediated thymocyte survival. Deletion of TCF-1 resulted in thymocyte apoptosis and down-regulated ROR3t, whereas transgenic expression of a stabilized 2-catenin (2-catTg), which activated TCF-1 constitutively, led to enhanced thymocyte survival and up-regulated ROR3t. In contrast to its survival role in thymocytes, 2-catTg up-regulated pro-apoptotic Bid and surface Fas, and enhanced super-antigen staphylococcal enterotoxin B (SEB)-induced deletion of peripheral T cells by promoting activation-induced cell death (AICD). We thus hypothesize that the 2- catenin/TCF pathway utilizes distinct mechanisms in the regulation of apoptosis in developing T cells and peripheral mature T cells. In the first two aims of this study, we propose to elucidate the mechanisms responsible for 2-catenin/TCF-1-regulated apoptosis in thymocytes and peripheral T cells. In the last aim, we will determine whether we can control T cell-dependent allograft rejection by manipulating 2-catenin-regulated T cell survival.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
MicroRNAs and Cardiac Regeneration.
microRNA和心脏再生。
DOI: 10.1161/circresaha.116.304377
发表时间: 2015-05-08
期刊: Circulation research
影响因子: 20.1
作者: [Hodgkinson CP, Kang MH, Dal-Pra S, Mirotsou M, Dzau VJ]
通讯作者: Dzau VJ
MicroRNA induced cardiac reprogramming in vivo: evidence for mature cardiac myocytes and improved cardiac function.
MicroRNA在体内诱导心脏重编程:成熟心肌细胞和改善心脏功能的证据。
DOI: 10.1161/circresaha.116.304510
发表时间: 2015-01-30
期刊: Circulation research
影响因子: 20.1
作者: [Jayawardena TM, Finch EA, Zhang L, Zhang H, Hodgkinson CP, Pratt RE, Rosenberg PB, Mirotsou M, Dzau VJ]
通讯作者: Dzau VJ
DOI: 10.1161/circresaha.116.308741
发表时间: 2017-04-28
期刊: Circulation research
影响因子: 20.1
作者: [Dal-Pra S, Hodgkinson CP, Mirotsou M, Kirste I, Dzau VJ]
通讯作者: Dzau VJ
Novel strategy for Enhancing miRNA as a Therapeutic for Cardiac Regeneration
  • 批准号:
    9237608
  • 项目类别:
  • 资助金额:
    $39.75万
  • 财政年份:
    2016
  • 负责人:
    Victor J Dzau
  • 依托单位:
MYOCARDIAL PROTECTION OF HASF IN ACUTE MI
  • 批准号:
    8363208
  • 项目类别:
  • 资助金额:
    $0.31万
  • 财政年份:
    2011
  • 负责人:
    Victor J Dzau
  • 依托单位:
Sfrp2 and Cardiac Progenitor Cells in Regenerative Response to Ischemic Injury
  • 批准号:
    8239268
  • 项目类别:
  • 资助金额:
    $43.8万
  • 财政年份:
    2006
  • 负责人:
    Victor J Dzau
  • 依托单位:
Sfrp2 as a Stem Cell Derived Paracrine Factor for Cardioprotection
  • 批准号:
    7145291
  • 项目类别:
  • 资助金额:
    $50.83万
  • 财政年份:
    2006
  • 负责人:
    Victor J Dzau
  • 依托单位:
海外基金